| Literature DB >> 34984227 |
Nariman Khan1, Saadia Waheed1, Rahaf Alkhateb2.
Abstract
Epithelioid hemangioendothelioma is a rare vascular malignancy that originates from vascular endothelial or pre-endothelial cells and is composed of epithelioid or histiocytoid cells. This malignancy has an incidence of approximately one per one million individuals and can occur in various regions of the body including the lungs, liver, bones, and soft tissues. The behavior of this cancer can range from indolent to aggressive and diagnosis and treatment are often delayed due to variable presentations and lack of established treatment guidelines. Here we present the case of a 27-year-old Hispanic male that presented with right groin pain, abdominal pain, and a fifty-pound weight loss over one year. The patient had a complex hospital course during which he was found to have an angiomyomatous hamartoma of his right groin area, postsurgical right inguinal wound infection with Actinomyces meyeri, and epithelioid hemangioendothelioma distal to the right iliac bifurcation. The patient is currently pending further imaging studies to evaluate candidacy for surgical resection and following with oncology for chemotherapeutic options.Entities:
Keywords: Actinomyces meyeri; angiomyomatous hamartoma; epithelioid hemangioendothelioma; wound infection
Year: 2021 PMID: 34984227 PMCID: PMC8717002 DOI: 10.22551/2021.32.0803.10187
Source DB: PubMed Journal: Arch Clin Cases ISSN: 2360-6975
Fig. 1Computed Tomography of the abdomen and pelvis - coronal view. Black arrow pointing to moderate right hydroureteronephrosis. Red arrow pointing to calcium containing lesion measuring 1.9 x 2.1 cm
Fig. 2Angiomyomatous hamartoma measuring 10 x 5 x 5 cm, excised from right groin
Fig. 3Immunohistochemistry stains show EHE tumor cells are positive for: A. vascular marker Erythroblast transformation-specific-related gene (anti-ERG antibody, x100); B. tumor specific marker Calmodulin-binding transcription activator 1 (anti-CAMTA1 antibody, x100); C. non-specific marker Cluster of differentiation 56 (anti-CD56 antibody, x100); D. vascular marker Cluster of differentiation 31 (anti-CD31 antibody, x100); E. Friend leukemia integration 1 transcription factor (anti-FLI1 antibody, x100). F. cords and single cells of large endothelial cells with abundant eosinophilic cytoplasm embedded in a myxohyaline stroma (HE, x200).